JK07

(Synonyms: SAL007)

JK07 (SAL007) is a conjugate of an antagonistic HER3 antibody and the EGF-binding domain of NRG-1. JK07 utilizes the NRG1 EGF-like domain to stimulate ErbB4 phosphorylation and HER2/HER4 dimerization and activate AKT signaling, while its antibody component antagonizes ErbB3, blocking NRG-1-induced HER3 dimerization and reducing ErbB3-mediated toxicity. JK07 enhances angiogenesis, reduces cardiac fibrosis and type I Collagen deposition, and improves cardiac function after myocardial infarction. JK07 improves left ventricular ejection fraction and attenuates left ventricular dilation in heart failure models. JK07 can be used for research on coronary microvascular dysfunction and head and neck squamous cell carcinoma.

Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.

  • Stockage:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Activité biologique
  • Chemical Information
  • Protocole
  • Pureté et documentation
  • Références
  • Help & FAQs
MOQ
Minimum order quantity
100 mg

Obtenir un devis En stock

Other size
Obtenir un devis
Please select quantity
Amount: USD 0.00